Resultados da pesquisa - cancer pre res (phila)

Pesquisas alternativas:
cancer pre » cancer prone (Expandir a Pesquisa), cancer pros (Expandir a Pesquisa), cancer prior (Expandir a Pesquisa)
pre res » pre rcs (Expandir a Pesquisa), pre pores (Expandir a Pesquisa), pre risc (Expandir a Pesquisa)

21

Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study

Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study

Por Feng, Tom, Sun, Xizi, Howard, Lauren E., Vidal, Adriana C., Gaines, Alexis R., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Publicado no Cancer Prev Res (Phila) (2015)

“...The role of metformin in prostate cancer chemoprevention remains unclear. REDUCE, which followed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

22

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence

Por Gruessner, Christine, Gruessner, Angelika, Glaser, Katherine, AbuShahin, Nisreen, Zhou, Yi, Laughren, Cynthia, Wright, Heather, Pinkerton, Samantha, Yi, Xiaofang, Stoffer, Jha'nae, Azodi, Masoud, Zheng, Wenxin, Chambers, Setsuko K.
Publicado em 2014

“... cancer development and (2) flutamide treatment of women at high risk (HR) for ovarian cancer may identify...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

23

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Por Zhu, Claire S., Pinsky, Paul F., Cramer, Daniel W., Ransohoff, David F., Hartge, Patricia, Pfeiffer, Ruth M., Urban, Nicole, Mor, Gil, Bast, Robert C., Moore, Lee E., Lokshin, Anna E., McIntosh, Martin W., Skates, Steven J., Vitonis, Allison, Zhang, Zhen, Ward, David C., Symanowski, James T., Lomakin, Aleksey, Fung, Eric T., Sluss, Patrick M., Scholler, Nathalie, Lu, Karen H., Marrangoni, Adele M., Patriotis, Christos, Srivastava, Sudhir, Buys, Saundra S., Berg, Christine D.
Publicado em 2011

“... biomarker panels have been described for ovarian cancer, few studies used pre-diagnostic samples to assess...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

24

$The Parity-Associated Microenvironmental Niche in the Omental Fat Band is Refractory to Ovarian Cancer Metastasis$

The Parity-Associated Microenvironmental Niche in the Omental Fat Band is Refractory to Ovarian Cancer Metastasis

Por Cohen, Courtney A., Shea, Amanda A., Heffron, C. Lynn, Schmelz, Eva M., Roberts, Paul C.
Publicado em 2013

“...Ovarian cancer is an insidious and aggressive disease of older women, typically undiscovered prior...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

25

Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention

Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention

Por Miller, Jessica A., Pappan, Kirk, Thompson, Patricia A., Want, Elizabeth J., Siskos, Alexandros, Keun, Hector C., Wulff, Jacob, Hu, Chengcheng, Lang, Julie E., Chow, H-H. Sherry
Publicado no Cancer Prev Res (Phila) (2014)

“... anti-cancer properties in preclinical models with effects on multiple cellular targets at varying...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

26

Physical Activity and Survival in Postmenopausal Women with Breast Cancer: Results from the Women’s Health Initiative

Physical Activity and Survival in Postmenopausal Women with Breast Cancer: Results from the Women’s Health Initiative

Por Irwin, Melinda L., McTiernan, Anne, Manson, JoAnn E., Thomson, Cynthia A., Sternfeld, Barbara, Stefanick, Marcia L., Wactawski-Wende, Jean, Craft, Lynette, Lane, Dorothy, Martin, Lisa W., Chlebowski, Rowan
Publicado em 2011

“...Although studies have shown that physically active breast cancer survivors have lower all-cause...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

27

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

Por Kimura, Takashi, McKolanis, John R., Dzubinski, Lynda A., Islam, Kazi, Potter, Douglas M., Salazar, Andres M., Schoen, Robert E., Finn, Olivera J.
Publicado em 2012

“...Cancer vaccines based on human tumor associated antigens (TAA) have been tested in patients...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

28

Genetic Variations in microRNA-related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk

Genetic Variations in microRNA-related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk

Por Ye, Yuanqing, Wang, Kenneth K., Gu, Jian, Yang, Hushan, Lin, Jie, Ajani, Jaffer A., Wu, Xifeng
Publicado em 2008

“... may increase the risk for esophageal cancer, we assessed the associations between esophageal cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

29

Role of E-cadherin in anti-migratory and anti-invasive efficacy of silibinin in prostate cancer cells

Role of E-cadherin in anti-migratory and anti-invasive efficacy of silibinin in prostate cancer cells

Por Deep, Gagan, Gangar, Subhash Chander, Agarwal, Chapla, Agarwal, Rajesh
Publicado em 2011

“...The epithelial-to-mesenchymal transition (EMT) in prostate cancer (PCA) cells is considered pre...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

30

3,3′-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down-regulation of Survivin

3,3′-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down-regulation of Survivin

Por Bhatnagar, Namrata, Li, Xia, Chen, Yue, Zhou, Xudong, Garrett, Scott H., Guo, Bin
Publicado em 2009

“... phosphorylation. Pre-treatment with DIM enhanced butyrate-induced apoptosis in colon cancer cells expressing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

31

Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening

Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening

Por Drescher, Charles W., Hawley, Sarah, Thorpe, Jason D., Marticke, Simone, McIntosh, Martin, Gambhir, Sanjiv, Urban, Nicole
Publicado em 2012

“...Ongoing ovarian cancer screening trials are investigating the efficacy of a two-step screening...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

32

Targeting Aberrant p70S6K Activation for Estrogen Receptor Negative Breast Cancer Prevention

Targeting Aberrant p70S6K Activation for Estrogen Receptor Negative Breast Cancer Prevention

Por Wang, Xiao, Yao, Jun, Wang, Jinyang, Zhang, Qingling, Brady, Samuel W., Arun, Banu, Seewaldt, Victoria L., Yu, Dihua
Publicado no Cancer Prev Res (Phila) (2017)

“... was highly activated in ER− pre-malignant breast lesions and ER− breast cancer. Additionally, p70S6K...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

33

Serum antibodies to HPV16 early proteins as biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer

Serum antibodies to HPV16 early proteins as biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer

Por Fakhry, Carole, Qualliotine, Jesse R., Zhang, Zhe, Agrawal, Nishant, Gaykalova, Daria, Bishop, Justin, Subramaniam, Rathan M, Koch, Wayne, Chung, Christine, Eisele, David W., Califano, Joseph, Viscidi, Raphael P.
Publicado no Cancer Prev Res (Phila) (2015)

“...Human papillomavirus (HPV) is responsible for increasing incidence of oropharyngeal cancer (OPC...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

34

Circulating RANKL and RANKL/OPG and breast cancer risk by ER and PR subtype: Results from the EPIC cohort

Circulating RANKL and RANKL/OPG and breast cancer risk by ER and PR subtype: Results from the EPIC cohort

Por Sarink, Danja, Schock, Helena, Johnson, Theron, Overvad, Kim, Holm, Marianne, Tjønneland, Anne, Boutron-Ruault, Marie-Christine, His, Mathilde, Kvaskoff, Marina, Boeing, Heiner, Lagiou, Pagona, Papatesta, Eleni-Maria, Trichopoulou, Antonia, Palli, Domenico, Pala, Valeria, Mattiello, Amalia, Tumino, Rosario, Sacerdote, Carlotta, Bueno-de-Mesquita, H.B(as), van Gils, Carla H, Peeters, Petra H, Weiderpass, Elisabete, Agudo, Antonio, Sánchez, Maria-José, Chirlaque, Maria-Dolores, Ardanaz, Eva, Amiano, Pilar, Khaw, Kay Tee, Travis, Ruth, Dossus, Laure, Gunter, Mark, Rinaldi, Sabina, Merritt, Melissa, Riboli, Elio, Kaaks, Rudolf, Fortner, Renée T.
Publicado no Cancer Prev Res (Phila) (2017)

“... influence breast cancer risk via activation of RANK signaling; this may be modulated by osteoprotegerin (OPG...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

35

Meat consumption, non-steroidal anti-inflammatory drugs, and mortality among colorectal cancer patients in the California Teachers Study

Meat consumption, non-steroidal anti-inflammatory drugs, and mortality among colorectal cancer patients in the California Teachers Study

Por Zell, Jason A., Ziogas, Argyrios, Bernstein, Leslie, Clarke, Christina A., Deapen, Dennis, Largent, Joan A., Neuhausen, Susan L., Stram, Daniel O., Ursin, Giske, Anton-Culver, Hoda
Publicado em 2010

“... with decreased mortality among colorectal cancer (CRC) patients. Here we investigated the association between pre...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

36

A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care

A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care

Por Shadfan, Basil H., Simmons, Archana R., Simmons, Glennon W., Ho, Andy, Wong, Jorge, Lu, Karen H., Bast, Robert C., McDevitt, John T.
Publicado no Cancer Prev Res (Phila) (2014)

“... screening. As no single biomarker is shed by all ovarian cancers, multiplexed biomarker panels promise...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

37

Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis

Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis

Por Preet, Anju, Qamri, Zahida, Nasser, Mohd W, Prasad, Anil, Shilo, Konstantin, Zou, Xianghong, Groopman, Jerome E., Ganju, Ramesh K.
Publicado em 2010

“...Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide; however, only...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

38

Large Prospective Study of Ovarian Cancer Screening in High-risk Women: CA125 Cut-point Defined by Menopausal Status

Large Prospective Study of Ovarian Cancer Screening in High-risk Women: CA125 Cut-point Defined by Menopausal Status

Por Skates, Steven J., Mai, Phuong, Horick, Nora K., Piedmonte, Marion, Drescher, Charles W., Isaacs, Claudine, Armstrong, Deborah K., Buys, Saundra S., Rodriguez, Gustavo C., Horowitz, Ira R., Berchuck, Andrew, Daly, Mary B., Domchek, Susan, Cohn, David E., Van Le, Linda, Schorge, John O., Newland, William, Davidson, Susan A., Barnes, Mack, Brewster, Wendy, Azodi, Masoud, Nerenstone, Stacy, Kauff, Noah D., Fabian, Carol J., Sluss, Patrick M., Nayfield, Susan G., Kasten, Carol H., Finkelstein, Dianne M., Greene, Mark H., Lu, Karen
Publicado em 2011

“...BACKGROUND: Previous screening trials for early detection of ovarian cancer in postmenopausal women...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

39

Acyl-Coenzyme A Binding Protein Regulates Beta Oxidation Required for Growth and Survival of Non-Small Cell Lung Cancer

Acyl-Coenzyme A Binding Protein Regulates Beta Oxidation Required for Growth and Survival of Non-Small Cell Lung Cancer

Por Harris, Fredrick T., Rahman, S.M. Jamshedur, Hassanein, Mohamed, Qian, Jun, Hoeksema, Megan D., Chen, Heidi, Eisenberg, Rosana, Chaurand, Pierre, Caprioli, Richard M., Shiota, Masakazu, Massion, Pierre P.
Publicado em 2014

“... the risk of having lung cancer. Because ACBP is known to regulate beta oxidation (β-oxidation), which...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

40

Effect of Low-fat Diets on Plasma Levels of NFκB-regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

Effect of Low-fat Diets on Plasma Levels of NFκB-regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

Por Heymach, John V., Shackleford, Terry J., Tran, Hai T., Yoo, Suk-Young, Do, Kim-Anh, Wergin, Melanie, Saintigny, Pierre, Vollmer, Robin T., Polascik, Thomas J., Snyder, Denise C., Ruffin, Mack T., Yan, Shaoyu, Dewhirst, Mark, Kunnumakkara, Ajaikumar B., Aggarwal, Bharat B., Demark-Wahnefried, Wendy
Publicado em 2011

“... cytokines and angiogenic factors (CAFs) in 145 men with prostate cancer enrolled in a pre-operative...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo